Douglas J. Lamont

2.1k total citations
38 papers, 1.4k citations indexed

About

Douglas J. Lamont is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Douglas J. Lamont has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 7 papers in Surgery. Recurrent topics in Douglas J. Lamont's work include Mitochondrial Function and Pathology (8 papers), Neurogenetic and Muscular Disorders Research (7 papers) and RNA modifications and cancer (7 papers). Douglas J. Lamont is often cited by papers focused on Mitochondrial Function and Pathology (8 papers), Neurogenetic and Muscular Disorders Research (7 papers) and RNA modifications and cancer (7 papers). Douglas J. Lamont collaborates with scholars based in United Kingdom, United States and Germany. Douglas J. Lamont's co-authors include Thomas M. Wishart, Thomas H. Gillingwater, Maica Llavero Hurtado, Samantha L. Eaton, Laura C. Graham, Chantal A. Mutsaers, Isabelle Nett, Michael A. J. Ferguson, Angela Mehlert and Diego Miranda‐Saavedra and has published in prestigious journals such as Nature Communications, Analytical Chemistry and Brain.

In The Last Decade

Douglas J. Lamont

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas J. Lamont United Kingdom	22	829	345	210	186	176	38	1.4k
Yoichi Ishida Japan	21	690 0.8×	75 0.2×	150 0.7×	171 0.9×	151 0.9×	68	1.5k
Simon Paine United Kingdom	19	679 0.8×	247 0.7×	135 0.6×	171 0.9×	258 1.5×	44	1.3k
Ollivier Milhavet France	22	1.8k 2.2×	108 0.3×	160 0.8×	389 2.1×	110 0.6×	33	2.3k
Alessia Farinazzo Italy	18	725 0.9×	263 0.8×	181 0.9×	75 0.4×	33 0.2×	28	1.2k
Osvaldo Rey United States	29	1.6k 1.9×	98 0.3×	203 1.0×	197 1.1×	199 1.1×	57	2.4k
Giovanna Clavarino France	18	1.3k 1.6×	68 0.2×	148 0.7×	165 0.9×	242 1.4×	25	2.0k
Sandra Beer‐Hammer Germany	24	699 0.8×	110 0.3×	98 0.5×	110 0.6×	153 0.9×	56	1.5k
Janet Weinstock Australia	20	514 0.6×	52 0.2×	253 1.2×	89 0.5×	160 0.9×	35	1.3k
Juan Gerez Switzerland	17	616 0.7×	54 0.2×	94 0.4×	182 1.0×	241 1.4×	35	1.3k
Amanda J. Ward United States	18	2.2k 2.6×	176 0.5×	442 2.1×	49 0.3×	104 0.6×	26	2.7k

Countries citing papers authored by Douglas J. Lamont

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Lamont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Lamont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Lamont more than expected).

Fields of papers citing papers by Douglas J. Lamont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Lamont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Lamont. The network helps show where Douglas J. Lamont may publish in the future.

Co-authorship network of co-authors of Douglas J. Lamont

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Lamont. A scholar is included among the top collaborators of Douglas J. Lamont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Lamont. Douglas J. Lamont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Román-Trufero, Mónica, Kevin Blighe, Paula Saavedra-García, et al.. (2025). An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation. Life Science Alliance. 8(5). e202403014–e202403014.

Kline, Rachel, Adrian Thomson, Douglas J. Lamont, et al.. (2025). Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA. Human Molecular Genetics. 34(6). 547–562. 2 indexed citations

Petit, Marine J., Quan Gu, Douglas J. Lamont, et al.. (2025). Multi-omics analysis of SFTS virus infection in Rhipicephalus microplus cells reveals antiviral tick factors. Nature Communications. 16(1). 4732–4732. 1 indexed citations

Arrázola, Macarena S., Matías Lira, Samantha L. Eaton, et al.. (2023). Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation. Aging Cell. 22(5). e13814–e13814. 19 indexed citations

László, Zsófia I., Douglas J. Lamont, Johannes Lehmann, et al.. (2023). Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS. Acta Neuropathologica. 146(3). 451–475. 8 indexed citations

Edwards, Ruairidh, Rachel Kline, Laura C. Graham, et al.. (2022). The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo. FEBS Journal. 289(13). 3894–3914. 10 indexed citations

László, Zsófia I., Rachel Kline, Samantha L. Eaton, et al.. (2022). Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex. Acta Neuropathologica Communications. 10(1). 156–156. 24 indexed citations

Nelvagal, Hemanth R., Maica Llavero Hurtado, Samantha L. Eaton, et al.. (2020). Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease. Scientific Reports. 10(1). 15157–15157. 9 indexed citations

Hurtado, Maica Llavero, Rosemary J. Jackson, Samantha L. Eaton, et al.. (2019). Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype. Acta Neuropathologica Communications. 7(1). 214–214. 59 indexed citations

10.

Young, D. F., David C. Busse, Andrew J. Davison, et al.. (2019). The switch between acute and persistent paramyxovirus infection caused by single amino acid substitutions in the RNA polymerase P subunit. PLoS Pathogens. 15(2). e1007561–e1007561. 36 indexed citations

11.

Kline, Rachel, Kosala N. Dissanayake, Maica Llavero Hurtado, et al.. (2019). Altered mitochondrial bioenergetics are responsible for the delay in Wallerian degeneration observed in neonatal mice. Neurobiology of Disease. 130. 104496–104496. 15 indexed citations

12.

Catenaccio, Alejandra, et al.. (2017). Molecular analysis of axonal-intrinsic and glial-associated co-regulation of axon degeneration. Cell Death and Disease. 8(11). e3166–e3166. 38 indexed citations

13.

Betz, Boris, Sara Jenks, Andrew D. Cronshaw, et al.. (2016). Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. Kidney International. 89(5). 1125–1135. 62 indexed citations

14.

Tape, Christopher J., Jonathan D. Worboys, John Sinclair, et al.. (2014). Reproducible Automated Phosphopeptide Enrichment Using Magnetic TiO₂ and Ti-IMAC. Analytical Chemistry. 86(20). 10296–10302. 62 indexed citations

15.

Wishart, Thomas M., Douglas J. Lamont, Ann K. Wright, et al.. (2012). Combining Comparative Proteomics and Molecular Genetics Uncovers Regulators of Synaptic and Axonal Stability and Degeneration In Vivo. PLoS Genetics. 8(8). e1002936–e1002936. 49 indexed citations

16.

Kelly, Patricia, et al.. (2012). Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. British Journal of Cancer. 106(5). 955–961. 40 indexed citations

17.

Mutsaers, Chantal A., Thomas M. Wishart, Douglas J. Lamont, et al.. (2011). Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Human Molecular Genetics. 20(22). 4334–4344. 79 indexed citations

18.

Nett, Isabelle, Angela Mehlert, Douglas J. Lamont, & Michael A. J. Ferguson. (2010). Application of electrospray mass spectrometry to the structural determination of glycosylphosphatidylinositol membrane anchors. Glycobiology. 20(5). 576–585. 8 indexed citations

19.

Kelly, Patricia, Kermit K. Murray, F. Paulin, et al.. (2010). Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. British Journal of Cancer. 103(2). 232–238. 22 indexed citations

20.

Nett, Isabelle, David Martin, Diego Miranda‐Saavedra, et al.. (2009). The Phosphoproteome of Bloodstream Form Trypanosoma brucei, Causative Agent of African Sleeping Sickness. Molecular & Cellular Proteomics. 8(7). 1527–1538. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact